Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | KDM1A | O60341 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | JAK1 | P23458 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3168997 | 1.00 | — | — | |
| SCHEMBL26112782 | 1.00 | SMN1; SMN2 (0.52) | SMN1; SMN2L3MBTL3L3MBTL1KDM1AMAOB | |
| Ammonia Solution, Strong SCHEMBL4295582 | 0.97 | SMN1; SMN2 (0.50) | SMN1; SMN2L3MBTL3L3MBTL1KDM1AMAOB | |
| SCHEMBL14862483 | 0.91 | SMN1; SMN2 (0.50) | SMN1; SMN2L3MBTL3L3MBTL1KDM1AMAOB | |
| SCHEMBL10086229 | 0.89 | SMN1; SMN2 (0.45) | SMN1; SMN2L3MBTL3L3MBTL1KDM1AMAOB | |
| SCHEMBL18116864 | 0.89 | SMN1; SMN2 (0.45) | SMN1; SMN2L3MBTL3L3MBTL1KDM1AMAOB | |
| SCHEMBL1827648 | 0.88 | SMN1; SMN2 (0.54) | SMN1; SMN2L3MBTL3L3MBTL1OPRL1ALDH1A1 | |
| SCHEMBL9425142 | 0.88 | SMN1; SMN2 (0.54) | SMN1; SMN2L3MBTL3L3MBTL1OPRL1ALDH1A1 | |
| SCHEMBL9558174 | 0.87 | SMN1; SMN2 (0.44) | SMN1; SMN2L3MBTL3L3MBTL1KDM1AMAOB | |
| SCHEMBL862083 | 0.87 | SMN1; SMN2 (0.44) | SMN1; SMN2L3MBTL3L3MBTL1KDM1AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250206623-A1 | CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE-TYPE ZEOLITE OBTAINED THEREFROM | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-06-26 | — | — | US | disclosed |
| EP-4501853-A1 | CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE TYPE ZEOLITE OBTAINED USING SAME | Sagami Chemical Research Institute (JP) | 2025-02-05 | — | — | EP | disclosed |
| CN-118742516-A | Cyclohexylidene diammonium salts, their use, and MSE-type zeolites therefrom | 公益财团法人相模中央化学研究所 | 2024-10-01 | — | — | CN | disclosed |
| WO-2023190472-A1 | CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE TYPE ZEOLITE OBTAINED USING SAME | 公益財団法人相模中央化学研究所 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023190472-A1 | CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE TYPE ZEOLITE OBTAINED USING SAME | 公益財団法人相模中央化学研究所 | 2023-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250206623-A1 | CYCLOHEXYLENEDIAMINIUM SALT, USE THEREOF, AND MSE-TYPE ZEOLITE OBTAINED THEREFROM | WASF2, SLC39A11, WEE1 | SMN1; SMN2 2496/4885L3MBTL3 3098/4885L3MBTL1 2165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.